SCPH
|Scpharmaceuticals Inc
NASDAQ
USD 4.20
+0.09|+2.19%
Current Price
USD 4.20
Change
+USD 0.09 (2.19%)
P/E Ratio
Dividend Yield
Market Cap
217.50M
Volume
424,761
Open
USD 4.17
Previous Close
USD 4.11
52-Week High
USD 5.65
52-Week Low
USD 1.94
About Scpharmaceuticals Inc
scPharmaceuticals Inc., a pharmaceutical company, focuses on developing and commercializing products to optimize the delivery of infused therapies and patient care. The company's lead product candidate is FUROSCIX that consists of formulation of furosemide, which is delivered through an on-body infusor for the treatment of congestion due to fluid overload in adults with chronic heart failure and kidney disease, as well as consists of subcutaneous loop diuretic that delivers IV equivalent diuresi...
Sector:Healthcare
Industry:Biotechnology
CEO:Mr. John H. Tucker
Employees:162
Headquarters:Burlington, USA
Website:www.scpharmaceuticals.com
Dividend History
Dividend Payments
| Declared Date | Record Date | Payment Date | Amount | Frequency |
|---|
Similar Companies
Explore Stocks by Sector
technology
finance
healthcare
Frequently Asked Questions